Ïã¸ÛÁùºÏ²Ê

XClose

Ïã¸ÛÁùºÏ²Ê News

Home
Menu

Ïã¸ÛÁùºÏ²Ê scientists to receive seed funding for most pressing cancer challenges

21 June 2021

Nine Ïã¸ÛÁùºÏ²Ê scientists have been shortlisted to work on some of the world’s toughest cancer problems, as part of the £80 million Cancer Grand Challenges.

cancer institute

In October 2020, Cancer Grand Challenges, founded by Cancer Research UK and the US National Cancer Institute, daredÌýthe global research community to take on nine of cancer’s most pressing issues.

The eight research themes taken forward were: Cachexia (a disorder that causes extreme weight loss and muscle wasting, and can include loss of body fat), e-cigarettes, extrachromosomal DNA, inflammation, macromolecules, normal phenotypes, senescence (the condition or process of deterioration with age), solid tumours in children.

Almost 170 teams across 61 countries submitted bold, innovative ideas, and Cancer Grand Challenges has now announced the 11 teams selected to compete for a share of £80m.ÌýÌý

Each team will now receive seed funding to get their ideas off the ground and make their full proposal.ÌýWinners will receive £20m and the freedom to unite above boundaries to unleash their scientific creativity.Ìý

Ïã¸ÛÁùºÏ²Ê scientists feature in six of the 11 teams shortlisted.Ìý

Dr Martin Pule (Ïã¸ÛÁùºÏ²Ê Cancer Institute), is co-lead for : Next Generation T cell therapies for childhood cancers. The Ïã¸ÛÁùºÏ²Ê Translational Research Office (TRO) supportedÌýapplication involves anÌýinternational team of researchers co-led by Dr Catherine Bollard, (George Washington University Children’s National Hospital) and including from Ïã¸ÛÁùºÏ²Ê, Professor Sergio Quezada (Ïã¸ÛÁùºÏ²Ê Cancer Institute), Professor Karen Page (Ïã¸ÛÁùºÏ²Ê Mathematics), Professor Marc-Olivier Coppens (Ïã¸ÛÁùºÏ²Ê Chemical Engineering) and Dr Karin Straathof (Ïã¸ÛÁùºÏ²Ê Great Ormond Institute for Child Health).

Research theme: Solid Tumours in Children

Summary: To develop effective, kinder treatments for children with solid tumours, we must explore new therapeutic approaches. The NGTC team’s vision is to bring engineered T cell therapies to the routine treatment of these children, within a decade.ÌýÌý

Dr Mariam Jamal-Hanjani (Ïã¸ÛÁùºÏ²Ê Cancer Institute), co-investigator on : CANcer Cachexia Action Network. The application involvesÌýinternational researchers, led by Dr Eileen White (Rutgers Cancer Institute of New Jersey, US).

Research theme: Cachexia

Summary: While fruitful, cancer cachexia research to date has yielded no effective therapies. The CANCAN team plans to take a new approach, guided by their central hypothesis: that cachexia is driven by the tumour itself, activating neurohormonal sickness pathways that lead to anorexia, metabolic dysfunction and tissue wasting.

Dr Mariam Jamal-Hanjani, (Ïã¸ÛÁùºÏ²Ê Cancer Institute), co-investigator on : extrachromosomal DNA in Cancer. An international research team is ledÌýby Professor Paul Mischel (Stanford University).

Research theme: Extrachromosomal DNA

Summary: Understanding the biology ofÌýecDNAÌýgeneration and action, and developing new ways to target these mechanisms inÌýcancerÌý

Dr Lion Shahab, (Ïã¸ÛÁùºÏ²Ê Institute of Epidemiology & Health), co-investigator on : International Consortium for the Population Impact of Electronic CigarEttes. The team is ledÌýby Professor Ann McNeill (King’s Colle London) and Professor Peter Shields (Ohio State University, US).

Research theme: E-cigarettes

Summary: A global effort to determine the population impact of e-cigarettes. The team hopes to address a major barrier to e-cigarette research: the need for additional rigorous, multidisciplinary studies to generate high quality international data sets.

Dr Laura Donovan and Dr Karin Straathof (both Ïã¸ÛÁùºÏ²Ê Great Ormond Institute for Child Health) and are co-investigators on . The team is led by Professor Dr Stefan Pfister (German Cancer Research Centre) and Professor Richard Gilbertson (University of Cambridge)

Research theme: Solid Tumours in Children

Summary: The first ever learning and data-driven computer model of normal and cancerous nervous system development, to support biological and therapeutic discovery.

Professor Juan Pedro Martinez-Barbera (Ïã¸ÛÁùºÏ²Ê Great Ormond Institute for Child Health), co-investigator, : Targeting Senescence Mechanisms to Arrest Cancer. TheÌýinternational team is led by Professor Scott Lowe (Memorial Sloan-Kettering Cancer Center, US), Professor Manuel Serrano (Institute for Research in Biomedicine, Spain) and Professor Jesus Gil (Imperial College London).

Research theme: Senescence

Summary: Improving the mechanistic understanding and detection of senescence to realise its potential in cancer treatment

Links

Image

  • Research at Ïã¸ÛÁùºÏ²Ê Cancer Institute:ÌýCredit Ïã¸ÛÁùºÏ²Ê Imagestore

Media Contact

Henry Killworth

Tel: +44 (0) 7881 833274

Email: h.killworth [at] ucl.ac.uk